Sinopharm Group Co Ltd
HKEX:1099
Sinopharm Group Co Ltd
Net Income (Common)
Sinopharm Group Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sinopharm Group Co Ltd
HKEX:1099
|
Net Income (Common)
¥8.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Net Income (Common)
¥3.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Net Income (Common)
¥2.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Net Income (Common)
¥2.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Net Income (Common)
¥2.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
17%
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Net Income (Common)
¥1.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
See Also
What is Sinopharm Group Co Ltd's Net Income (Common)?
Net Income (Common)
8.9B
CNY
Based on the financial report for Jun 30, 2023, Sinopharm Group Co Ltd's Net Income (Common) amounts to 8.9B CNY.
What is Sinopharm Group Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
15%
Over the last year, the Net Income (Common) growth was 14%. The average annual Net Income (Common) growth rates for Sinopharm Group Co Ltd have been 13% over the past three years , 10% over the past five years , and 15% over the past ten years .